{"schema_version":"secwatch.filing_event.v1","accession":"0002046386-26-000037","form_type":"8-K","ticker":"MDLN","cik":"0002046386","company_name":"Medline Inc.","filed_at":"2026-06-12T20:20:00+00:00","discovered_at":"2026-06-12T20:21:00.325532+00:00","generated_at":"2026-06-12T20:39:27.744820+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Medline shareholders elect 12 directors, approve executive compensation and auditor at 2026 annual meeting","bullets":["All 12 director nominees elected; highest withheld votes were for Robert R. Schmidt with 43,976,750 withheld.","Advisory vote on executive compensation approved: 1,189,280,399 for, 6,203,145 against.","Advisory vote on frequency set to one year (1,195,424,539 votes); board adopts annual advisory vote.","Ratification of Ernst & Young as independent auditor for FY2026 approved: 1,211,242,117 for, 156,205 against."],"urls":{"canonical":"https://secwatch.observer/filing/0002046386-26-000037","json":"https://secwatch.observer/filing/0002046386-26-000037.json","markdown":"https://secwatch.observer/filing/0002046386-26-000037.md","text":"https://secwatch.observer/filing/0002046386-26-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2046386/000204638626000037/0002046386-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2046386/000204638626000037/mdln-20260611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:39:27.744820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e2355551d8ec4158bf2a4571d01d2f845992750","claim":"Medline Inc. shareholders approved Advisory Vote on the Frequency of Votes on Executive Compensation at the 2026-06-11 meeting.","evidence_excerpt":"Stockholders approved, on an advisory basis, a frequency of one year for future advisory votes on the Company’s executive compensation as follows:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/2046386/000204638626000037/0002046386-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"8aed2aa362db4ed6815c278f0d81b3598b3e76d0","claim":"Medline Inc. shareholders approved Election of 12 director nominees named in the proxy statement at the 2026-06-11 meeting.","evidence_excerpt":"Stockholders elected each of the 12 nominees to serve as a director of the Company for a one-year term expiring at the Company’s 2027 Annual Meeting of Stockholders as follows:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/2046386/000204638626000037/0002046386-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"d453caade8213509086490bbf2f3529ab16662c2","claim":"Medline Inc. shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-06-11 meeting.","evidence_excerpt":"Stockholders approved, on an advisory basis, the Company’s executive compensation as follows:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/2046386/000204638626000037/0002046386-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"fab46f9e255a9f065ba8fa01853ee3d23b0afbcf","claim":"Medline Inc. shareholders approved Ratification of the Selection of Ernst & Young LLP as Independent Auditor for Fiscal Year 2026 at the 2026-06-11 meeting.","evidence_excerpt":"Stockholders ratified the selection of Ernst & Young LLP as the Company’s independent auditor for fiscal year 2026 as follows:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/2046386/000204638626000037/0002046386-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}